UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000051087 |
|---|---|
| Receipt number | R000057488 |
| Scientific Title | A Phase II study of Gemcitabine, Cisplatin and Bevacizumab for the patients with first recurrent and refractory ovarian clear cell carcinoma |
| Date of disclosure of the study information | 2024/04/01 |
| Last modified on | 2024/05/16 12:16:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2023/05/17 14:28:57 | ||
| 2 | Update | 2024/03/08 19:30:50 | Date of disclosure of the study information |
|
| 3 | Update | 2024/05/16 12:16:52 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
